Skip to main content

Engineered in vitro disease models.

Publication ,  Chapter
Benam, KH; Dauth, S; Hassell, B; Herland, A; Jain, A; Jang, K-J; Karalis, K; Kim, HJ; MacQueen, L; Mahmoodian, R; Musah, S; Torisawa, Y-S ...
January 2015

The ultimate goal of most biomedical research is to gain greater insight into mechanisms of human disease or to develop new and improved therapies or diagnostics. Although great advances have been made in terms of developing disease models in animals, such as transgenic mice, many of these models fail to faithfully recapitulate the human condition. In addition, it is difficult to identify critical cellular and molecular contributors to disease or to vary them independently in whole-animal models. This challenge has attracted the interest of engineers, who have begun to collaborate with biologists to leverage recent advances in tissue engineering and microfabrication to develop novel in vitro models of disease. As these models are synthetic systems, specific molecular factors and individual cell types, including parenchymal cells, vascular cells, and immune cells, can be varied independently while simultaneously measuring system-level responses in real time. In this article, we provide some examples of these efforts, including engineered models of diseases of the heart, lung, intestine, liver, kidney, cartilage, skin and vascular, endocrine, musculoskeletal, and nervous systems, as well as models of infectious diseases and cancer. We also describe how engineered in vitro models can be combined with human inducible pluripotent stem cells to enable new insights into a broad variety of disease mechanisms, as well as provide a test bed for screening new therapies.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

DOI

Publication Date

January 2015

Volume

10

Start / End Page

195 / 262

Related Subject Headings

  • Pathology
  • Pathology
  • Models, Biological
  • In Vitro Techniques
  • Humans
  • Disease
  • Animals
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Benam, K. H., Dauth, S., Hassell, B., Herland, A., Jain, A., Jang, K.-J., … Ingber, D. E. (2015). Engineered in vitro disease models. (Vol. 10, pp. 195–262). https://doi.org/10.1146/annurev-pathol-012414-040418
Benam, Kambez H., Stephanie Dauth, Bryan Hassell, Anna Herland, Abhishek Jain, Kyung-Jin Jang, Katia Karalis, et al. “Engineered in vitro disease models.,” 10:195–262, 2015. https://doi.org/10.1146/annurev-pathol-012414-040418.
Benam KH, Dauth S, Hassell B, Herland A, Jain A, Jang K-J, et al. Engineered in vitro disease models. In 2015. p. 195–262.
Benam, Kambez H., et al. Engineered in vitro disease models. Vol. 10, 2015, pp. 195–262. Epmc, doi:10.1146/annurev-pathol-012414-040418.
Benam KH, Dauth S, Hassell B, Herland A, Jain A, Jang K-J, Karalis K, Kim HJ, MacQueen L, Mahmoodian R, Musah S, Torisawa Y-S, van der Meer AD, Villenave R, Yadid M, Parker KK, Ingber DE. Engineered in vitro disease models. 2015. p. 195–262.

DOI

Publication Date

January 2015

Volume

10

Start / End Page

195 / 262

Related Subject Headings

  • Pathology
  • Pathology
  • Models, Biological
  • In Vitro Techniques
  • Humans
  • Disease
  • Animals
  • 3202 Clinical sciences